| J3111 | Injection, romosozumab-aqqg, 1 mg | 36,750 | $10 | $294K |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 16,500 | $20 | $280.5K |
| J0897 | Injection, denosumab, 1 mg | 12,480 | $20 | $237.1K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 28,000 | $1 | $112K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,010 | $30 | $104.3K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 250 | $90 | $23.1K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 310 | $60 | $18.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 15,750 | $1 | $15.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 80 | $120 | $9.3K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 520 | $10 | $6.8K |